(19)
(11) EP 4 680 276 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24716066.6

(22) Date of filing: 15.03.2024
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
C12N 15/67(2006.01)
C12N 15/69(2006.01)
C12N 15/10(2006.01)
C12N 15/68(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/67; C12N 2310/532; C12P 19/34
(86) International application number:
PCT/US2024/020317
(87) International publication number:
WO 2024/192422 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.03.2023 US 202363490517 P

(71) Applicant: Flagship Pioneering Innovations VI, LLC
Cambridge, MA 02142 (US)

(72) Inventors:
  • BRONSTEIN, Revital
    Cambridge, MA 02142 (US)
  • HOBERT, Elissa, Magdalene
    Cambridge, MA 02142 (US)
  • KAZAKOV, Teymur, Spartakovich
    Cambridge, MA 02142 (US)
  • PAEK, Ki, Young
    Cambridge, MA 02142 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) IMMUNOGENIC COMPOSITIONS AND USES THEREOF